Derek Hicks, EVP, Chief Business Officer at Intellia Therapeutics, Inc. (NTLA), sold 7,754 shares at $29.46 ($228K) on 2024-01-03, disclosed to the SEC on 2024-01-05.
Open-market sale of $228k NTLA by EVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.46 | 3,877 | $114K | 50.0% |
| 2 | $29.46 | 3,877 | $114K | 50.0% |
| Total | $29.46 avg | 7,754 | $228K | 100% |
| Filing → |